Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice, first published as justification

PLUVICTO - Northern California VA

36C26127N0055

Department of Veterans Affairs, 261-Network Contract Office 21. Pharmaceutical Preparation Manufacturing.

9 open like this View on SAM.gov Markdown

Awarded

Novartis Pharmaceuticals Corporation

$3,086,483.40 on the award notice, October 1, 2026, contract 36F79720D0180

Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities

This one was awarded in 2026

9 like it are open now in pharmaceutical preparation manufacturing

All 9 open in pharmaceutical preparation manufacturing

Description

As published on SAM.gov.

Awardee: NOVARTIS PHARMACEUTICALS CORPORATION

Award Amount: $3,086,483.40 (including option to increase quantity)

Period of Performance: 10/01/2026 - 09/30/2027

Limited Source Justification is attached.

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Novartis Pharmaceuticals Corporation
UEI
NG61ZA8TADW3
CAGE
04520
Vendor location
East Hanover, NJ
Contract
36C26126F0007 under 36F79720D0180, delivery order
Obligated
$3,987,496.80
Actions
1 between October 1, 2025 and October 1, 2025
Competition
Full and Open Competition, 1 offer received
Described as
Pluvicto Drug
Match
solicitation number 36C26126F0007 was reused as the contract number; same awarding office 36C261 (high confidence)
Record
USAspending award page
Recipient
Novartis Pharmaceuticals Corporation
UEI
NG61ZA8TADW3
CAGE
04520
Vendor location
East Hanover, NJ
Contract
36C26126F0008 under 36F79720D0180, delivery order
Obligated
$1,348,841.44, potential $3,399,743
Actions
2 between October 1, 2025 and October 1, 2026
Competition
Full and Open Competition, 1 offer received
Described as
Lutathera Cancer Therapy
Match
solicitation number 36C26126F0008 was reused as the contract number; same awarding office 36C261 (high confidence)
Record
USAspending award page
Recipient
Novartis Pharmaceuticals Corporation
UEI
NG61ZA8TADW3
CAGE
04520
Vendor location
East Hanover, NJ
Contract
36C26127N0055 under 36F79720D0180, delivery order
Obligated
$1,851,890.04, potential $3,086,483
Actions
1 between October 1, 2026 and October 1, 2026
Competition
Full and Open Competition, 1 offer received
Described as
Pluvcito Ndc: 69488-0010-61
Match
solicitation number 36C26127N0055 was reused as the contract number; same awarding office 36C261 (high confidence)
Record
USAspending award page
Recipient
Novartis Pharmaceuticals Corporation
UEI
NG61ZA8TADW3
CAGE
04520
Vendor location
East Hanover, NJ
Contract
36C26127N0063 under 36F79720D0180, delivery order
Obligated
$4,115,311.20
Actions
1 between October 1, 2026 and October 1, 2026
Competition
Full and Open Competition, 1 offer received
Described as
Pluvicto Ndc: 69488-0010-61
Match
solicitation number 36C26127N0063 was reused as the contract number; same awarding office 36C261 (high confidence)
Record
USAspending award page
Recipient
Novartis Pharmaceuticals Corporation
UEI
NG61ZA8TADW3
CAGE
04520
Vendor location
East Hanover, NJ
Contract
36F79720D0180
Obligated
$0.00, potential $20,809,675,896
Actions
68 between January 3, 2024 and July 27, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
Pharmaceuticals
Match
award number 36F79720D0180 equals the contract number; same sub-agency 3600 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 1, 2025

    Justification, originally special notice

    Justification and Approval Notice

    SAM.gov, notice 28aa306305524208a5d729f6edad42f4

    2 revisions on SAM
    • October 1, 2025: publish, justification
    • June 4, 2025: publish, special notice

  2. October 2, 2025

    Justification

    PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML

    SAM.gov, notice 989e5b8b353642b8a071507670bdb678

    1 revisions on SAM
    • October 2, 2025: publish, justification

  3. October 10, 2025

    Special notice

    PLUVICTO | LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML VA Phoenix Healthcare System

    Due October 31, 2025 at 1:00 PM EDT. SAM.gov, notice ec5c22a742b640c89c1f8ff374a126d6

    1 revisions on SAM
    • October 10, 2025: publish, special notice

  4. January 8, 2026

    Award notice, originally justification

    Pluvicto | VA Phoenix Healthcare System

    Awarded to Novartis Pharmaceuticals Corporation for $4,984,371. SAM.gov, notice 6dcee1676c804ae398aa4f70e62ba55f

    2 revisions on SAM
    • January 8, 2026: publish, justification
    • January 8, 2026: publish, award notice

  5. January 8, 2026

    Justification

    LSJ | Pluvicto | VA Phoenix Healthcare System

    SAM.gov, notice 857a6976b24a4b728ccc10c41a0e31fd

    2 revisions on SAM
    • January 8, 2026: publish, justification
    • January 8, 2026: publish, award notice

  6. March 3, 2026

    Justification

    Radiopharmaceutical PLUVICTO

    Awarded to Novartis Pharmaceuticals Corporation for $4,732,608. SAM.gov, notice f35d3000335f4f348dbe4993452441a1

    1 revisions on SAM
    • March 3, 2026: publish, justification

  7. October 1, 2026

    Award notice

    PLUVICTO Palo Alto VA

    Awarded to Novartis Pharmaceuticals Corporation for $4,115,311. SAM.gov, notice 30d0a8fd40fd46f8b7053462b39af931

    1 revisions on SAM
    • October 1, 2026: publish, award notice

  8. October 1, 2026

    Award notice

    Awarded to Novartis Pharmaceuticals Corporation for $3,086,483. SAM.gov, notice f6b41ed0cab84404b33f2ddae965dea4

    1 revisions on SAM
    • October 1, 2026: publish, award notice

Points of contact